Study findings could provide blueprint for regulating lab-developed diagnostic tests
The FDA’s policy deviations specific to COVID tests might be employed in ongoing oversight of all such tests.
Press ReleaseJun | 25 | 2020
Simple Bed-side Test Detects Bleeding Risk in Patients After Surgery or Major Injury
Type
Centers and Departments
Related Content
- Press Release
- Apr | 22 | 2021
Study models economic impact of proposed law to regulate high-risk diagnostic tests
Legislation under consideration in U.S. Congress would increase regulatory oversight of certain diagnostic tests, and a new study by researchers at MGH and colleagues from several other institutions demonstrates that its impact will depend on key details in the bill’s final language.
- Press Release
- Sep | 8 | 2020
Elevated clotting factor V levels linked to worse outcomes in severe COVID-19 infections
ICU patients on ventilators who had abnormally high factor V activity were at higher risk for blood clots, and when factor V was lower, the risk for death was increased.
- Press Release
- Sep | 8 | 2020
Los niveles elevados del factor de coagulación V se relacionan con peores resultados en las infecciones graves por el COVID-19
Los pacientes hospitalizados con infecciones graves por el COVID-19 que tienen altos niveles del factor V (proteína de coagulación sanguínea) corren un riesgo elevado de sufrir lesiones graves por coágulos sanguíneos como la trombosis venosa profunda o la embolia pulmonar.
- Press Release
- Jul | 23 | 2020
New CRISPR C-to-G DNA base editor expands the landscape of precision genome editing
The new base editing platform may help researchers understand and correct genetic diseases by selective editing of single DNA 'letters' across nucleobase classes.
- Press Release
- Jun | 27 | 2019
Mutational "hotspots" in cancer genomes may not necessarily drive cancer growth
A study by investigators from the Massachusetts General Hospital Cancer Center has found that, contrary to common assumptions, the fact that a specific genetic mutation is frequently found in particular tumors may not signify that mutation drives cancer development and progression.
1of
6